GENFIT Share Price Euronext Paris
Stocks
GNFT
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Euronext Paris
|
||
| - PTS | - |
|
| 15/09 | French and Benelux stocks-Factors to watch on September 15 | RE |
| 15/09 | France's Genfit Plans Phase 2a Trial of Liver Failure Treatment | MT |
| Market Cap | 58Cr 0 66Cr 55Cr 50Cr 93Cr 6.36TCr 93Cr 654.06Cr 252.4Cr 3.24TCr 249.12Cr 243.59Cr 10TCr | P/E 2026 * |
29.8x | P/E 2027 * | 65.9x |
|---|---|---|---|---|---|
| Enterprise Value | 53Cr 0 60Cr 50Cr 45Cr 85Cr 5.8TCr 85Cr 596.26Cr 230.09Cr 2.95TCr 227.1Cr 222.06Cr 9.49TCr | EV / Sales 2026 * |
5.26x | EV / Sales 2027 * | 4.02x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: GENFIT
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | +2.71% | +0.33% | +28.59% | 4.63TCr | |
| -1.12% | +1.78% | +40.07% | +27.26% | 4.39TCr | |
| -3.04% | -6.29% | +322.27% | +517.36% | 4.09TCr | |
| -0.74% | +1.25% | +2.32% | +67.94% | 3.99TCr | |
| -0.50% | +0.67% | +11.79% | +40.51% | 2.95TCr | |
| -0.46% | +4.22% | +21.99% | +124.21% | 1.71TCr | |
| -0.97% | -10.17% | - | - | 1.55TCr | |
| -0.57% | +8.12% | +22.15% | +38.93% | 1.52TCr | |
| -3.14% | +31.91% | -10.60% | - | 1.4TCr | |
| Average | -0.99% | +3.76% | +51.29% | +120.69% | 2.92TCr | |
| Weighted average by Cap. | -1.02% | +1.87% | +64.69% | +130.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 0 12Cr 9.47Cr 8.6Cr 16Cr 1.1TCr 16Cr 113.43Cr 44Cr 561.06Cr 43Cr 42Cr 1.81TCr | 13Cr 0 15Cr 12Cr 11Cr 20Cr 1.4TCr 20Cr 143.66Cr 55Cr 710.6Cr 55Cr 54Cr 2.29TCr |
| Net income | 2.29Cr 0 2.62Cr 2.16Cr 1.96Cr 3.68Cr 251.75Cr 3.69Cr 26Cr 9.99Cr 127.99Cr 9.86Cr 9.64Cr 411.83Cr | 90.67L 0 1.04Cr 85.61L 77.74L 1.46Cr 100Cr 1.46Cr 10Cr 3.96Cr 51Cr 3.91Cr 3.82Cr 163.21Cr |
| Net Debt | -5.11Cr -0 -5.86Cr -4.83Cr -4.38Cr -8.21Cr -562.38Cr -8.24Cr -58Cr -22Cr -285.92Cr -22Cr -22Cr -919.99Cr | -6.76Cr -0 -7.75Cr -6.38Cr -5.79Cr -11Cr -743.41Cr -11Cr -76Cr -29Cr -377.96Cr -29Cr -28Cr -1.22TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- GNFT Stock
- GNFT Stock
Select your edition
All financial news and data tailored to specific country editions
